Your browser doesn't support javascript.
COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.
DeGroff, A; Miller, J; Sharma, K; Sun, J; Helsel, W; Kammerer, W; Rockwell, T; Sheu, A; Melillo, S; Uhd, J; Kenney, K; Wong, F; Saraiya, M; Richardson, L C.
  • DeGroff A; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA. Electronic address: adegroff@cdc.gov.
  • Miller J; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA.
  • Sharma K; Totally Joined for Achieving Collaborative Techniques, LLC, USA.
  • Sun J; Totally Joined for Achieving Collaborative Techniques, LLC, USA.
  • Helsel W; Information Management Services, Inc., USA.
  • Kammerer W; Information Management Services, Inc., USA.
  • Rockwell T; Information Management Services, Inc., USA.
  • Sheu A; Information Management Services, Inc., USA.
  • Melillo S; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA.
  • Uhd J; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA.
  • Kenney K; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA.
  • Wong F; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA.
  • Saraiya M; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA.
  • Richardson LC; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA.
Prev Med ; 151: 106559, 2021 10.
Article in English | MEDLINE | ID: covidwho-1294320
ABSTRACT
Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services during January-June 2020. We found the total number of NBCCEDP-funded breast and cervical cancer screening tests declined by 87% and 84%, respectively, during April 2020 compared with the previous 5-year averages for that month. The extent of declines varied by geography, race/ethnicity, and rurality. In April 2020, screening test volume declined most severely in Health and Human Services Region 2 - New York (96% for breast, 95% for cervical cancer screening) compared to the previous 5-year averages. The greatest declines were among American Indian/Alaskan Native women for breast cancer screening (98%) and Asian Pacific Islander women for cervical cancer screening (92%). Test volume began to recover in May and, by June 2020, NBCCEDP breast and cervical cancer screening test volume was 39% and 40% below the 5-year average for that month, respectively. However, breast cancer screening remained over 50% below the 5-year average among women in rural areas. NBCCEDP programs reported assisting health care providers resume screening.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Breast Neoplasms / Uterine Cervical Neoplasms / COVID-19 Type of study: Diagnostic study / Experimental Studies / Randomized controlled trials Limits: Female / Humans Country/Region as subject: North America Language: English Journal: Prev Med Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Breast Neoplasms / Uterine Cervical Neoplasms / COVID-19 Type of study: Diagnostic study / Experimental Studies / Randomized controlled trials Limits: Female / Humans Country/Region as subject: North America Language: English Journal: Prev Med Year: 2021 Document Type: Article